🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yehia I. Mohamed

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-5192-3804

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial”.

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00427-1

N/A

4.7DataRank · unranked

263 citations

Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean‐Nicolas Vauthey, Sunyoung S. Lee +24 more

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients

Oncotarget(2022)10.18632/oncotarget.28322

N/A

0.434DataRank · unranked

17 citations

Dan G. Duda, Muhammad O. Awiwi, Sunyoung S. Lee, Lina Altameemi, Lianchun Xiao +13 more

Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma

Journal of Immunotherapy and Precision Oncology(2024)10.36401/jipo-24-6

N/A

0.330DataRank · unranked

8 citations

Betül Gök Yavuz, Yehia I. Mohamed, Sunyoung S. Lee, James C. Yao, Zishuo Ian Hu +13 more

Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2300706120

N/A

0DataRank · unranked

46 citations

Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T. Ryujin, Jian Yu Huang +8 more

Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features

The Oncologist(2023)10.1093/oncolo/oyad329

N/A

0DataRank · unranked

1 citations

Russell G. Witt, Khaled M. Elsayes, Ali Baiomy, Lianchun Xiao, Sarah Palmquist +14 more

Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.05.531188

N/A

0DataRank · unranked

5 citations

Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T. Ryujin, Jian Yu Huang +7 more

Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab

Cancer Biomarkers(2024)10.3233/cbm-230431

N/A

0DataRank · unranked

12 citations

Sunyoung S. Lee, Tarık Demir, Shadi Chamseddine, Zishuo Ian Hu, Lianchun Xiao +17 more

IGF-Child-Turcotte-Pugh score as a predictor of treatment outcome in Child-Pugh A, advanced hepatocellular carcinoma patients undergoing sorafenib therapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e16660

N/A

0DataRank · unranked

1 citations

Aliya Qayyum, Manal M. Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia +9 more

Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma(2024)10.2147/jhc.s452564

N/A

0DataRank · unranked

2 citations

Michael LaPelusa, Lianchun Xiao, Yehia I. Mohamed, Sunyoung Lee, Zishuo Hu +8 more

Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib

Oncotarget(2021)10.18632/oncotarget.27924

N/A

0DataRank · unranked

3 citations

Sunyoung Lee, Lianchun Xiao, Manal M. Hassan, Aliya Qayyum, Rikita Hiatia +12 more

Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma

Frontiers in Oncology(2022)10.3389/fonc.2022.986305

N/A

0DataRank · unranked

24 citations

Abedul Haque, Deeksha Vishwamitra, Manal M. Hassan, Lianchun Xiao, Bhawana George +11 more